Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 11, 2000

View Archived Issues

Testosterone buccal tablet enters late-stage clinical testing

Dimethaid receives approval for Pennsaid lotion in U.K.

Oxford GlycoSciences and Glaxo Wellcome enter proteomics alliance

Neurochem demonstrates proof of concept for AD compound

Immunosuppressive drug in development at Isotechnika shows promise in phase I

Biogen licenses novel neurotrophic protein from NsGene

BMS extends license for PathoGenome database

Viventia Biotech's H11 enters phase I/II oncology trial

ARANESP effective given once weekly, and possibly less frequently, in treating anemia

Early clinical evidence of efficacy, safety of UCN-01 plus fludarabine phosphate in CLL

Gilead obtains rights to Glaxo Wellcome TS inhibitor

Apomate imaging agent receives orphan drug status from FDA

ASH news: proteasome inhibitor LDP-341 as attractive new drug for multiple myeloma, CLL

Heparin inhibition of complement activation: comparative effects of Neutralase and protamine

Synaptic discovers peptide ligand that potentially inhibits metastasis

FDA approves Protopic for the treatment of eczema

New combretastatin prodrug displays enhanced solubility and antitumor activity

Positive results for new glycopeptide show dramatic and sustained reductions in bacterial load

Myobloc is first FDA-approved treatment for cervical dystonia

Derivatives of 3-deoxy-desmycosin with antimicrobial activity designed by Pliva

New macrolides from Pliva exhibit broad spectrum of activity

Pyrazole-based antiinflammatory agents patented by Dr. Reddy's team

Nycomed Imaging identifies novel X-ray contrast agents

Inhibitors of Lp-PLA2 from SB reportedly useful for atherosclerosis

AstraZeneca presents new carboxypeptidase U inhibitors and use thereof

Highly selective dopamine D4 receptor partial agonists identified at German university

ConjuChem initiates phase I trial of novel analgesic product

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...